NFKB1 and malignant colon neoplasm: Yamamoto et al. previously demonstrated that aspirin inhibits the activation of NF-κB pathway by inhibiting IKKβ activity in colon cancer cells and suggested that this specific interference may be involved in the antineoplastic property [56].